City
Epaper

US redirects vaccine manufacturing supplies allowing India to make additional 20 million Covid vaccine doses

By ANI | Updated: May 29, 2021 08:10 IST

The US government on Friday (local time) has redirected orders of critical vaccine manufacturing supplies, which will allow India to make over 20 million additional doses of AstraZeneca COVID-19 vaccines.

Open in App

The US government on Friday (local time) has redirected orders of critical vaccine manufacturing supplies, which will allow India to make over 20 million additional doses of AstraZeneca COVID-19 vaccines.

The information was shared by Acting Assistant Secretary, Bureau of South & Central Asian Affairs, Dean Thompson.

"We've redirected one of our own orders of critical vaccine manufacturing supplies, which will allow India to make over 20 million additional doses of AstraZeneca COVID-19 vaccine," said Dean Thompson.

He also informed that US has provided over USD 500 million in COVID-19 relief supplies to India to fight against the pandemic.

"In total, the US government, state governments, US companies, and private citizens have provided over USD 500 million in COVID-19 relief supplies to India," said the Acting Assistant Secretary.

External Affairs Minister (EAM) S Jaishankar on Friday (local time) expressed gratitude to United States for strong support and solidarity during the COVID-19 pandemic. The minister's counterpart, US Secretary of State Antony Blinken said that the two countries were united in tackling the COVID-19 pandemic together.

Earlier, the White House had announced that US will be sending 60 million doses of the AstraZeneca vaccine to other countries starting from June 2021.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Bureau of south & central asian affairsAntony blinkenAstrazenecaAstrazeneca plc.Dean thompsonAnthony blinkenTony blinkenAstrazeneca plcAstra zeneca
Open in App

Related Stories

InternationalAntony Blinken Says Israel Accepted Bridging Proposal for Gaza Ceasefire Talks, Urges Hamas To Do Same

HealthDCGI Orders Withdrawal of AstraZeneca’s Anti-Cancer Drug Olaparib for Certain Treatments

HealthAfter Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

International Realted Stories

International"Red letter day for India and Indian Navy": Defence expert Ranjeet Rai welcomes Rafale deal

InternationalMansarovar Yatra to resume this summer: China's Foreign Ministry

InternationalWhat we saw in Kashmir is unacceptable, Pakistan needs to deal with terror activities: Israel's diplomat

InternationalCanadians vote in vital elections under Trump’s shadow

InternationalSouth Africa records eight per cent increase in cross-border travellers during Easter